Improving HPV vaccine uptake in underserved populations
Intervention to Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine Series
This study is trying to see if educational workshops can help young people in underserved communities understand the importance of the HPV vaccine and encourage them to get vaccinated.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Denver, Colorado) |
| Trial ID | NCT04611022 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on educating underserved populations about the importance of the HPV vaccine through workshops led by trained Community Health Educators. Participants will receive educational materials developed by the National Cancer Institute, including presentations and videos, aimed at adolescents and young adults who have not started or completed the HPV vaccine series. The study will assess the effectiveness of this educational intervention using pre- and post-tests, as well as follow-up surveys to track vaccination rates and referrals to care. The goal is to enhance knowledge and increase the completion rates of the HPV vaccine among participants.
Who should consider this trial
Good fit: Ideal candidates include Denver Health patients aged 18-26 who have not started or completed the HPV vaccine series, as well as parents of adolescents aged 9-17 in the same situation.
Not a fit: Patients who have already completed the HPV vaccine series or do not meet the age and residency criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly increase HPV vaccination rates, thereby reducing the incidence of HPV-related cancers in underserved populations.
How similar studies have performed: Other studies have shown success with educational interventions aimed at increasing HPV vaccination rates, suggesting that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Be a Denver Health patient\* 18-26 years old, who has not started or completed the HPV vaccine series (Vaccine completion for this age group is 3 doses). 2. Be a parent of a Denver Health adolescent patient\* aged 9-17 years old, who has not started or completed the HPV vaccine series. (Vaccine completion is 2 doses for 9-14-year-old, and 3 doses for 14-17-year old) 3. English and/or Spanish Speaking 4. Stated willingness to comply with all study procedures and be available for the duration of the study * Denver Health patients will be identified from one of the following clinics; Denver Health Clinics Eastside Adult Clinic, Eastside Women's Care Clinic, Westside Adult Clinic, Westside Women's Care Clinic, Pavilion C: Women's Care Clinic, La Casa-Quigg Newton Family Health Center, Lowry Family Health Center, Montbello Family Health Center, Westwood Family Health Center, Parkhill Family Health Center, Webb Center For Primary Care, Pena Southwest Clinic Exclusion Criteria: 1. Individuals who do not meet eligibility criteria, including individuals who do not speak English or Spanish \[at the discretion of the CHE or PN upon recruitment\] 2. Decisionally-challenged adults with cognitive or personality impairment or due to intoxication (alcohol or drugs) that might interfere with their ability to consent or participate in the study \[at the discretion of the CHE or PN upon recruitment\] 3. Individuals from vulnerable populations (e.g., inmates, homeless, pregnant women, and those with auditory impairment \[at the discretion of the CHE or PN upon recruitment\] 4. Individuals under the age of 18 years.
Where this trial is running
Denver, Colorado
- University of Colorado Hospital — Denver, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Evelinn Borrayo — University of Colorado, Denver
- Study coordinator: Sindy Gonzalez
- Email: Sindy.Gonzalez@CUAnschutz.edu
- Phone: 303-724-5445
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.